L. Alpern - Feb 1, 2024 Form 4 Insider Report for Arteris, Inc. (AIP)

Role
VP and General Counsel
Signature
/s/ Paul Alpern
Stock symbol
AIP
Transactions as of
Feb 1, 2024
Transactions value $
-$62,581
Form type
4
Date filed
2/5/2024, 04:19 PM
Previous filing
Jan 4, 2024
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIP Common Stock Award $0 +50K +133.26% $0.00 87.5K Feb 1, 2024 Direct F1
transaction AIP Common Stock Options Exercise $5.6K +10K +11.43% $0.56* 97.5K Feb 1, 2024 Direct F2
transaction AIP Common Stock Options Exercise $750 +1.25K +1.28% $0.60* 98.8K Feb 1, 2024 Direct F3
transaction AIP Common Stock Sale -$61.2K -10K -10.12% $6.12 88.8K Feb 1, 2024 Direct F4, F5
transaction AIP Common Stock Sale -$7.71K -1.25K -1.41% $6.17 87.5K Feb 1, 2024 Direct F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AIP Common Stock Options Exercise $0 -1.25K -14.29% $0.00 7.5K Feb 1, 2024 Common Stock 1.25K $0.60 Direct F3
transaction AIP Common Stock Options Exercise $0 -10K -5.88% $0.00 160K Feb 1, 2024 Common Stock 10K $0.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 50,000 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 1/16th of the total RSUs on 4/1/2024 and in equal quarterly installments thereafter. The RSUs have no expiration date.
F2 25% of the total shares vested on August 26, 2020; thereafter, 1/48th of the total shares have vested monthly for 3 years. beginning on September 26, 2020.
F3 25% of the total shares vested on July 23, 2021; thereafter, 1/48th of the total shares vest monthly for 3 years. beginning on August 23, 2021.
F4 Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on August 16, 2023.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.01 to $6.19 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 Includes 87,521 restricted stock units.